Abstract |
Methyl palmoxirate, an inhibitor of long-chain fatty acid oxidation, was administered by gavage (0, 1, 5, or 20 mg/kg/day) to female rats over the last third of gestation and throughout lactation. Weight gain (mid- and high-dosage group) and survivability (high-dosage group) were significantly (p less than or equal to 0.05) reduced in offspring of methyl palmoxirate-treated dams as compared to control offspring. Mid- and high-dosage male offspring found dead after Day 4 of lactation exhibited grossly distended bladders and renal pelves. A dosage-related increased incidence of dilated renal pelves was observed in both sexes at necropsy of 21-day-old mid- and high-dosage group pups. Microscopic examination of the urinary tracts of a number of affected pups revealed renal parenchymal atrophy and urethral obstruction. Drug disposition studies indicated lactating pups were exposed to significant amounts of methyl palmoxirate via mammary secretions. Cross-fostering experimentation suggested that some of the adverse effects observed in offspring were due to lactational, rather than in utero, exposure.
|
Authors | M F Kenel, J H Krayer, K T Ng, C H Kircher |
Journal | Toxicology and applied pharmacology
(Toxicol Appl Pharmacol)
Vol. 93
Issue 1
Pg. 127-36
(Mar 30 1988)
ISSN: 0041-008X [Print] United States |
PMID | 3353998
(Publication Type: Journal Article)
|
Chemical References |
- Epoxy Compounds
- Ethers, Cyclic
- Fatty Acids
- Propionates
- Proteins
- methyl 2-tetradecylglycidate
|
Topics |
- Animals
- Blood Urea Nitrogen
- Dose-Response Relationship, Drug
- Epoxy Compounds
(toxicity)
- Ethers, Cyclic
(toxicity)
- Fatty Acids
(metabolism)
- Female
- Hydronephrosis
(chemically induced)
- Kidney
(drug effects, pathology)
- Lactation
- Milk
(metabolism)
- Oxidation-Reduction
- Pregnancy
- Propionates
(toxicity)
- Proteins
(metabolism)
- Rats
- Rats, Inbred Strains
- Urethra
(drug effects)
|